Oak Ridge Investments’s Glaukos GKOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Buy
10,586
+283
+3% +$35.8K 0.08% 114
2026
Q1
$1.11M Buy
10,303
+1,245
+14% +$140K 0.07% 117
2025
Q4
$1.02M Sell
9,058
-1,415
-14% -$135K 0.06% 123
2025
Q3
$854K Sell
10,473
-222
-2% -$20.4K 0.06% 130
2025
Q2
$1.1M Sell
10,695
-402
-4% -$37.7K 0.08% 113
2025
Q1
$1.09M Sell
11,097
-53
-0.5% -$7.07K 0.09% 111
2024
Q4
$1.67M Buy
+11,150
New +$1.54M 0.13% 97

Other funds holding GKOS

Oak Ridge Investments's GKOS Position: Q2 2026 in Review

Oak Ridge Investments increased its Glaukos (GKOS) stake by 2.7% in Q2 2026, buying an estimated $35.8K and bringing the position to 10,586 shares worth $1.48M. The position accounts for 0.08% of the portfolio, ranked #114.

Oak Ridge Investments first reported a position in GKOS in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.67M in Q4 2024. 60 funds tracked by Wall St. Rank hold GKOS as of Q2 2026.

  • Oak Ridge Investments held 10,586 shares of Glaukos worth $1.48M as of Q2 2026.
  • Oak Ridge Investments bought 283 Glaukos shares in Q2 2026, an estimated $35.8K.
  • Glaukos made up 0.08% of Oak Ridge Investments's portfolio in Q2 2026, its #114 holding.
  • Oak Ridge Investments first reported a position in Glaukos in Q4 2024 and has held it in 7 quarters since.
  • Oak Ridge Investments's Glaukos position peaked at $1.67M in Q4 2024.
  • 60 funds tracked by Wall St. Rank held Glaukos as of Q2 2026.

Based on Oak Ridge Investments's 13F filing for Q2 2026, filed 21 Jul 2026.